# PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome

> **NCT02037672** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 36 (actual)

## Conditions studied

- PCOS
- Obesity

## Interventions

- **DRUG:** metformin
- **DRUG:** metformin and roflumilast

## Key facts

- **NCT ID:** NCT02037672
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037672, "PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02037672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*